BL
CME icon

Balentine LLC’s CME Group CME Stock Holding History

Balentine LLC’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,884
Closed -$1.05M – 255
2024
Q1 		$1.05M Sell
4,884
-2,086
-30% -$438K 0.03% 185
2023
Q4 		$1.47M Buy
6,970
+1,317
+23% +$281K 0.05% 129
2023
Q3 		$1.13M Buy
5,653
+367
+7% +$73K 0.04% 132
2023
Q2 		$979K Buy
5,286
+298
+6% +$55.1K 0.03% 156
2023
Q1 		$955K Sell
4,988
-3,882
-44% -$702K 0.03% 187
2022
Q4 		$1.49M Buy
8,870
+2,748
+45% +$478K 0.05% 131
2022
Q3 		$1.08M Buy
6,122
+3,571
+140% +$706K 0.04% 143
2022
Q2 		$522K Sell
2,551
-3,262
-56% -$691K 0.02% 303
2022
Q1 		$1.38M Buy
5,813
+4,170
+254% +$979K 0.05% 116
2021
Q4 		$375K Buy
+1,643
New +$362K 0.01% 214
2020
Q3 		– Sell
-477
Closed -$78K – 287
2020
Q2 		$78K Buy
477
+130
+37% +$23.3K ﹤0.01% 178
2020
Q1 		$60K Buy
347
+295
+567% +$58.7K ﹤0.01% 163
2019
Q4 		$10K Buy
52
+7
+16% +$1.44K ﹤0.01% 346
2019
Q3 		$10K Hold
45
– – ﹤0.01% 341
2019
Q2 		$9K Buy
+45
New +$8.3K ﹤0.01% 326
2019
Q1 		– Sell
-30
Closed -$6K – 440
2018
Q4 		$6K Buy
+30
New +$5.54K ﹤0.01% 310
2018
Q1 		– Sell
-54
Closed -$8K – 151
2017
Q4 		$8K Hold
54
– – ﹤0.01% 479
2017
Q3 		$7K Hold
54
– – ﹤0.01% 489
2017
Q2 		$7K Hold
54
– – ﹤0.01% 466
2017
Q1 		$6K Hold
54
– – ﹤0.01% 454
2016
Q4 		$6K Hold
54
– – ﹤0.01% 439
2016
Q3 		$6K Buy
54
+6
+13% +$626 ﹤0.01% 397
2016
Q2 		$5K Buy
+48
New +$4.54K ﹤0.01% 404

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Balentine LLC's CME Position: Q2 2024 in Review

Balentine LLC sold out of CME Group (CME) in Q2 2024, closing a stake of 4,884 shares — an estimated $1.05M sold.

Balentine LLC first reported a position in CME in Q2 2016 and held it in 23 quarters. The position peaked at $1.49M in Q4 2022. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Balentine LLC reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 4,884 CME Group shares in Q2 2024, an estimated $1.05M.
  • Balentine LLC first reported a position in CME Group in Q2 2016 and held it in 23 quarters.
  • Balentine LLC's CME Group position peaked at $1.49M in Q4 2022.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.